Daily non-political popular news in brief.

Impaired Gene Helps Nonsmall-cell Lung Cancer Resist Drug

Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease, researchers at the University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center at Dallas report in the cover article of the Oct. 1 edition of Cancer Research.

Read more »

Keywords: impaired, gene, nonsmall-cell, lung, cancer, resist, drug, nonsmall, cell

« Previous | Next »

Similar news on "Impaired Gene Helps Nonsmall-cell Lung Cancer Resist Drug":

1. Modeling lung cancer
   02-12-2007 · EurekAlert!
   In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
   Similar news · Read more »
   
2. Multicenter study nets new lung tumor-suppressor gene
   08-05-2007 · EurekAlert!
   Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice. The researchers report in the journal Nature that LKB1 is not only a "tumor-suppressor" gene for nonsmall cell lung cancer in mice, it also may be more powerful than other, better-known suppressors. The study will be published on the journal's Web site on Aug. 5.
   Similar news · Read more »
   
3. Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer
   04-17-2007 · EurekAlert!
   A cancer-suppressing gene has been successfully delivered into the tumors of stage four lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at the University of Texas M. D. Anderson Cancer Center. The gene, FUS1, also was found to be active in the metastatic nonsmall cell lung cancer tumors.
   Similar news · Read more »
   
4. Gene analysis might explain ethnic differences in sensitivity to chemotherapy in lung cancer
   04-23-2007 · EurekAlert!
   Analysis of three genetic mechanisms that cause nonsmall cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.
   Similar news · Read more »
   
5. Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer
   06-05-2007 · EurekAlert!
   Some patients with advanced nonsmall cell lung cancer have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.
   Similar news · Read more »
   
6. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
   09-25-2007 · EurekAlert!
   Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in nonsmall cell lung cancer. They told the European Cancer Conference in Barcelona that not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them.
   Similar news · Read more »
   
7. Gene analysis might explain ethnic differences in sensitivity to chemotherapy in lung cancer
   04-23-2007 · UT Southwestern Medical Center
   Analysis of three genetic mechanisms that cause non-small cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.
   Similar news · Read more »
   
8. Other highlights in the Nov. 13 JNCI
   11-13-2007 · EurekAlert!
   Other highlights in the Nov. 13 JNCI include a simple model to predict breast cancer risk, the link between smoking and rectal cancer, research into how a cancer drug causes heart damage, a gene that may inhibit lung cancer, BRCA1's influence on drug response, and the difficulties assigning patients to cancer subtypes.
   Similar news · Read more »
   
9. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
   07-17-2007 · EurekAlert!
   Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6 percent compared with surgery alone.
   Similar news · Read more »
   
10. Dual gene therapy suppresses lung cancer in preclinical test
    01-15-2007 · EurekAlert!
    Combination gene therapy delivered in lipid-based nanoparticles drastically reduces the number and size of human non-small cell lung cancer tumors in mice, researchers at The University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center report in the January 15 edition of Cancer Research.
    Similar news · Read more »